Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

99 Views

Poster

1505 - A Meta-Analysis Investigating Response Rates of Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B-Cell Lymphomas

Primary Author / Presenter(s)

PZ

Pier Luigi Zinzani, MD, PhD

Institute of Hematology “Seràgnoli” University of Bologna
Bologna, Italy

Co-Author(s)

RW

Rhys Williams, PhD

BeOne Medicines Ltd
San Carlos, California, United States
MX

Mei Xue, MBA

BeOne Medicines Ltd., USA
San Carlos, California, United States
BN

Binod Neupane, PhD

Evidera
Montreal, Quebec, Canada
PZ

Priccila Zuchinali, PhD

Evidera
Montreal, Quebec, Canada
HB

Heather Burnett, MSc

Heather Burnett HEOR
Toronto, Ontario, Canada
LM

Leyla Mohseninejad, PhD

BeOne Medicines Ltd
Schiphol, Noord-Holland, Netherlands
KY

Keri Yang, PhD

BeOne Medicines Ltd., USA
San Carlos, California, United States